Gilead Withdraws Request for Special Orphan Status on Experimental Virus Treatment

·

·

Gilead Withdraws Request for Special Orphan Status on Experimental Virus Treatment

Bowing to criticism that it was exploiting the coronavirus pandemic, the drugmaker Gilead said on Wednesday that it would no longer seek orphan-drug status for remdesivir, an experimental drug that is being tested as a possible treatment. The Food and Drug …
See Original Article

Mylan Says India's Lockdown Won't Affect Drug Production

Mylan said drug factories are exempt from the stay-at-home order issued in India, and that Mylan’s facilities there continue to operate. The company said drug factories are exempt from the stay-at-home order issued in India. Shares of the generic drugmaker …
See Original Article

Nike Beats on Revenue – Investors Should Trade in This Range

Nike (NKE) – Get Report took a 25-cent-a-share fiscal-third-quarter charge for Covid-19 and beat analysts’ estimates on revenue, but the stock failed within a price gap going back to March 11. Given the extreme broad-market volatility, my call is to trade the …
See Original Article

Georgia-based auto-dealer chain backs out of $1B deal for luxury stores

Asbury Automotive Group Inc. is pulling the plug on one of the richest acquisitions of car dealerships in history and stocking up on cash instead. The Duluth, Georgia-based retailer has delivered notice to Park Place Dealerships that it’s terminating the $1 …
See Original Article

This best-selling bidet can replace toilet paper—and its on sale

Recommendations are independently chosen by Reviewed’s editors. Purchases you make through our links may earn us a commission. With toilet paper becoming a hot commodity, bidets seem to be the next best thing. Despite the mystery surrounding this …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.